Analysis of temporal survival trends: considerations and best practice
Open Access
- 22 February 2025
- journal article
- research article
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 25 (1) , 1-11
Abstract
Monitoring quality of healthcare is vital to ensure that changes made to clinical practice achieve the intended goals. Assessing temporal trends due to the accumulated effect of all changes in clinical practice in a given period is essential in quality monitoring. However, this assesment is compplicated by the fact that numerous of changes might occour over time unrelated to the clinical practice. Furthermore, the methods used to assess temporal trends in patient outcomes in the medical literature are heterogeneous, making it difficult to compare results between studies. In this paper, we describe methods that enable researchers to investigate temporal trends in survival data and we discuss their pros and cons. Numerous unrelated changes may occur over time which must be taken into account and disentangled when assessing the improvement in clinical management. The methods and interpretation thereof are exemplified on patients with diffuse large B-cell lymphoma from the Danish lymphoma registry.Keywords
Funding Information
- Danish Data Science Academy (2023-1210)
- Kræftens Bekæmpelse (R274-A17146)
This publication has 43 references indexed in Scilit:
- The Will Rogers phenomenon: the effect of different diagnostic criteriaJournal of the Neurological Sciences, 2009
- Consequences of dichotomizationPharmaceutical Statistics, 2008
- Flexible parametric models for relative survival, with application in coronary heart diseaseStatistics in Medicine, 2007
- Estimating and modeling the cure fraction in population-based cancer survival analysisBiostatistics, 2006
- Regression models for relative survivalStatistics in Medicine, 2003
- Temporal Trends (1973–1997) in Survival of Patients With Esophageal Adenocarcinoma in The United States: A Glimmer of Hope?American Journal of Gastroenterology, 2003
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Cancer Survival Corrected for Heterogeneity in Patient Withdrawal1982
- Corrected group prognostic curves and summary statisticsJournal of Chronic Diseases, 1982